Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Standard of Care × Clear all

NCT03808337 2026-02-27

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Phase 2 Recruiting

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT07250477 2026-02-09

Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03808662 2026-02-04

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

NCT03217071 2024-10-23

Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer

Phase 2 Completed

12 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung

NCT04405401 2023-12-12

SUPPRESS-NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03628144 2020-09-10

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03472053 2020-05-19

A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis